Jeffrey M. Liebmann

Sustained Nano Systems LLC is a company that develops products for post-cataract surgery treatment. The company is based in Westhampton Beach, NY and was founded by Barry M. Libin, who has been the CEO since incorporation. The company's products include dex-sa, which delivers dexamethasone to the subconjunctival space to treat postoperative inflammation and pain, and lat-la, a single extraocular injectable administration of a six-month release prostaglandin analog for glaucoma treatment. The company also develops SNS ret-la, which prevents blood vessel growth for over a year in a standard rabbit model of corneal angiogenesis.

Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer.

The American Glaucoma Society supports glaucoma specialists and scientists through the advancement of education and research.

InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York.